ScholarIQanswers from OpenAlex

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure

PaperCitations, authors & open-access status

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure have?

ScholarIQcitation count

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure has 3,129 citations in the OpenAlex counts ScholarIQ stores.

When was Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure published?

ScholarIQyear

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure has 1984 year in the ScholarIQ index.

What is the open-access status of Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure?

ScholarIQoa status

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure has closed oa status in the ScholarIQ index.

What is the DOI of Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure?

ScholarIQdoi

The DOI for Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure is on the source record.

What is the PMID of Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure?

ScholarIQpmid

The PMID for Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure is on the source record.

What is the OpenAlex record for Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure?

ScholarIQopenalex

The OpenAlex for Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial